Alimera Sciences Inc. (ALIM) Dividend History
Alimera Sciences, Inc. is a biopharmaceutical company based in Alpharetta, Georgia that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. The company's main focus is on diseases affecting the back of the eye, or retina. Its main product is ILUVEAN, an fluocinolone acetonide intravitreal implant. Alimera was founded in June 2003 by Dan Myers, Daniel White, Dave Holland and Mark Testerman. Three of the founders were previously part of Ciba Vision Ophthalmics, which was renamed Novartis Ophthalmics following a merger.
Last update 11/27/2022
Dividend Yield Summary
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
| Dividends | - | - | - | - | - | - |
| Average Price | 1.36 | 1.02 | 1.64 | 5.41 | 7.45 | 5.48 |
| Yield | - | - | - | - | - | - |
Dividend History
No history of dividends
| Date | Amount Per Share | Note |